[Abstract Only] Observational Study Suggests Women with Heart Failure May Need Lower Doses of ACE Inhibitors or ARBs and β blockers than Men
25 Aug, 2019 | 21:31h | UTCIdentifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study – The Lancet (link to abstract – $ for full-text)
Related Commentary on Twitter
BIOSTAT-CHF trial (n=1,710) lowest mortality rates occurred at 100% of the recommended dose of ACEIs & β blockers for men, but women showed significant lower risk at 50% of the recommended doses with no further improvement at higher dose levels.https://t.co/OL2PIPl1aF
— Dr Rani Khatib (@DrRaniKhatib) August 23, 2019